Related Experiment Video
Updated: Apr 30, 2026

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
Published on: December 3, 2019
Cardiovascular disease in patients with chronic human immunodeficiency virus infection
Ricardo O Escárcega1, Joseph J Franco1, Bhalaghuru Chokkalingam Mani1
1Temple University Hospital, Department of Medicine, Section of Cardiology, Philadelphia, PA, United States.
Insights
Human immunodeficiency virus (HIV) infection is linked to diverse cardiovascular diseases. A multidisciplinary heart team approach is essential for managing and preventing cardiac complications in HIV patients.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- Globally, 34 million people were living with HIV in 2011.
- Cardiovascular disease accounts for 6.5% of AIDS-related mortality.
- HIV-associated cardiovascular disease encompasses various conditions like cardiomyopathy and coronary artery disease.
Purpose of the Study:
- To review the spectrum of cardiovascular diseases associated with HIV infection.
- To discuss the complex pathophysiology and multifactorial nature of these conditions.
- To highlight challenges in managing HIV patients with cardiovascular disease, including drug interactions.
Main Methods:
- Literature review exploring HIV-related cardiovascular conditions.
- Discussion of pathophysiology, clinical manifestations, and management strategies.
- Emphasis on prevention and the role of collaborative care.
Main Results:
- HIV infection is associated with diverse cardiovascular pathologies including cardiomyopathy, coronary artery disease, dyslipidemia, and arrhythmias.
- Management is complicated by drug-drug interactions and treatment side effects.
- Prevention strategies are similar to the general population but require careful consideration of HIV-specific factors.
Conclusions:
- A collaborative 'heart team' approach involving cardiovascular specialists and HIV care providers is crucial.
- This integrated care model ensures medication safety and facilitates goal-directed prevention plans.
- Effective management and prevention of cardiovascular disease in HIV patients require a multidisciplinary strategy.
Abstract:
In 2012, the United Nations estimated that globally, 34 million people were living with human immunodeficiency virus (HIV) infection at the end of 2011. About 6.5% of AIDS-related mortality is attributable to cardiovascular disease. HIV related cardiovascular disease is diverse. In this review we explore the different disease states associated with HIV such as cardiomyopathy, coronary artery disease, dyslipidemia, electrocardiographic abnormalities, prolonged QT interval and sudden death. The pathophysiology of these numerous diseases is complex and multifactorial. Current management of these patients is challenging due to multiple drug-drug interactions and side effects. However, the approach to prevention is quite familiar, taking on the same rules that apply for any patient to minimize cardiovascular disease risk. The challenges are many, therefore for HIV patients who present after a cardiovascular event, or for prevention of cardiovascular disease, the concept of a heart team is essential, where cardiovascular specialists and the HIV care team work side by side to ensure safety of medications (avoid drug interactions) and to institute a goal directed prevention plan of care.
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Sexually Transmitted Infections
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Retrovirus Life Cycles
Rheumatic Heart Disease I: Introduction
Cardiomyopathy II: Dilated Cardiomyopathy

